Episode # 209 • 14 Jan 2025
Management of Bladder Cancer: Insights from Community Practice
Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting.
This podcast is supported by
Timestamps
00:00 - Introduction
04:47 - Community Practice and New Technologies
09:59 - Clinical Trials for Bladder Cancer Care
15:52 - Patient Referrals
29:27 - Exploring New Treatment Options
30:46 - Bladder Sparing Strategies
32:21 - BCG Treatment and Surveillance
47:04 - Implementation of New Therapies
54:27 - Future Directions
Resources
You may also like
More about this episode
The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.